Cannabinoids and chronic pain

Reading this collection

Chronic pain is heterogeneous by definition, and the studies here reflect that: they differ in population, pain type, preparation and endpoint. Comparisons between them are rarely like-for-like.

Two neighbouring pages narrow the question further — cancer pain and neuropathic pain each have their own clinical literature and their own page.

The evidence in this library

8 source-linked studies — 8 scientific source. Each links to its source; identifiers are shown where the record carries them.

1. CBD Use and Effectiveness: Real-World Evidence from Clinical Practice

   2021 · BMC · CBD, Full Spectrum

   Scientific source

   DOI 10.1186/s42238-021-00078-w

2. Therapeutic Efficacy of Cannabidiol — CB2, TRPV1, 5-HT1A Mechanisms

   2021 · PMC / NCBI · CBD

   Scientific source

   PMID 33585159 · PMCID PMC7880228

3. A Balanced Approach for Cannabidiol Use in Chronic Pain

   2020 · PMC / NCBI · CBD

   Scientific source

   PMCID PMC7204604

4. Long-term Effects of CBD on Chronic Pain: A Cohort Study

   2020 · PMC / NCBI · CBD

   Scientific source

   PMCID PMC7216052

5. CBD blocks multiple pain signaling pathways

   NCBI

   Scientific source

   PMID 26951675

6. CBD modulates ECS for chronic pain without tolerance

   PMC / NCBI

   Scientific source

   PMCID PMC8450066

7. CBD modulates pain via TRPV1, 5-HT1A, CB2

   NCBI

   Scientific source

   PMID 27338416

8. Full-spectrum superior to CBD isolate for chronic pain

   NCBI

   Scientific source

   PMID 32588042

How to read this evidence

These are the boundaries recorded against the studies above, reproduced as written in the library:

• Mechanistic/symptom-support rationale only; avoid disease-cure or product-specific proof unless clinical endpoint exists.
• Use as evidence-informed ECS/cannabinoid research navigation; avoid product-specific disease claims.